Bar Chart

Toolkit for the Elimination of Asbestos Related Diseases 

(Edition 2013)

2013 tk cover.JPG

The Toolkit for the Elimination of Asbestos-Related Diseases (Edition 2013) was developed in the year 2013 to serve as a concise and easy-to-use reference source of knowledge, technologies and information that merit attention for the purpose of eliminating asbestos-related diseases (ARDs).

For this edition, the traditional public health approach of prevention was considered to be the basic means to tackle ARDs. Many countries, especially those which are rapidly developing, continue to use asbestos at alarming levels. The developing countries in Asia are at the forefront of this trait.

This edition focused on the asbestos hazard identification, asbestos exposure assessment, diagnostic tools for ARDs, the economic cost burden of asbestos exposure as well as risk communication. Our hope then was that any party with concern on ARDs can have something to benefit from this edition. Whoever the beneficiary, a core principle to bear in mind, is that the most effective means to prevent ARDs is to stop using asbestos. This position is unchanged as of today in 2020.

 

Content

List of contributing Authors

1. Asbestos Exposure Assessment, Risk Identification, and Substitutes 

1A. Asbestos Hazard Identification

1B. Asbestos Exposure Assessment and Control in Occupational Settings

1C. Epidemiology of ARDs *

1D. High Risk Occupation and Industries in regard to ARDS

1E. Asbestos Substitute

2. Asbestos-Related Legislations and Regulations 

2A. Case Studies of Asbestos-Related National Legislations

2Aa. Asbestos-related legislation of Korea

2Ab. Preventive measures to eliminate ARDs in Singapore *

2B. Asbestos-Related Policies in International Organizations *

2C. Asbestos-Related Guidelines

3. Diagnostic Tools for ARDs 

3A. Existing International Diagnostic Criteria and Tools *

3B. Clinical Diagnosis of Mesothelioma

3C. Clinical Diagnosis of Asbestos-Induced Lung Cancer

3D. Clinical Diagnosis of Asbestosis

3E. Clinical Diagnosis of Pleural Plague, Pleural Thickening and Pleural Effusion

3F. Pathology of Mesothelioma

4. Economic Cost/Burden Incurred by Asbestos Exposure and ARDs 

4A. Economic Cost/Burden Incurred by Asbestos Exposure

4B. Economic Cost/Burden Incurred by ARDs

5. Risk Communication 

5A. Collection and /or Development of Awareness-Raising Materials Aimed at the General Public

5B. Collection and /or Development of Interview Films and Documented Testimonies of ADRs Victims

5C. Collection of Existing Education and Training Materials regarding Occupational Safety and Health Aimed at Workers Handling or with Possible Exposure to Asbestos

5D. Mesothelioma from the Patient’s Perspective *

*Please note, Chapters marked (*) and additional information is available in the Supplementary Material:

 

Factsheets

(Large file size approximately 120 MB)

COMING SOON

Toolkit for the Elimination of Asbestos-Related Diseases for Developing Countries (Edition 2021)